Physician profile
Dillon Macky
NPI 1306420021
$1,851.75
in general payments reported to CMS, 2019-2025
12 companies · $675 in 2025
The $675 reported for 2025 was more than what 83% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $578 · 2023: $52.58 · 2024: $546 · 2025: $675.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,266 · Travel and Lodging: $8.13.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,265.63 |
| Travel and Lodging | $8.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $352.24 | 2024 | Truelok, Tl-Hex Truelok Hexapod System |
| Stryker Corporation | $291.85 | 2022-2025 | Mako, Sonopet Iq |
| Medline Industries LP | $190.10 | 2025 | |
| Cgg Medical INC | $175.65 | 2025 | |
| Becton, Dickinson and Company | $164.73 | 2022 | |
| Linvatec Corporation | $129.40 | 2022 | |
| Arthrex, INC. | $122.88 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $110.16 | 2022 | |
| Bioventus LLC | $105.44 | 2025 | Exogen Ultrasound Bone Healing System |
| Team 1, LLC | $87.47 | 2024-2025 | |
| Biotissue Holdings INC. | $74.53 | 2023-2024 | |
| Depuy Synthes Sales INC. | $47.30 | 2025 | Velys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dillon Macky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.